Why Do PSA Levels Fluctuate?

PSA levels shift constantly because the protein is not a cancer-specific marker; it responds to prostate size, inflammation, infection, sexual activity, medications, and even the time of day blood is drawn. A man who gets tested twice in the same month without any change in health can see readings differ by around 20 percent, which is the normal biological noise of this particular blood test. Understanding why those numbers move is the key to avoiding unnecessary panic, unnecessary biopsies, and missed diagnoses.

What PSA Is and Where It Comes From

PSA, or prostate-specific antigen, is a protein produced by both normal and malignant prostate cells. Its biological job is to liquefy semen after ejaculation. Most PSA stays inside the prostate ducts, but a small amount leaks into the bloodstream, and that spillover is what a PSA test measures.¹ Androgens, particularly testosterone and its derivative DHT, directly regulate how much PSA the prostate makes. When androgen levels rise, PSA production goes up; when they fall, PSA drops.² This hormonal link explains why so many different life circumstances can push PSA around.

Normal Biological Variation

Even when nothing medically interesting is happening, PSA readings bounce around from one blood draw to the next. A study of over 800 men in a screening population found that the average difference between two blood draws was about 20 percent for men with PSA in the low range, and about 10 to 12 percent for men with higher readings. That variation was larger than the run-to-run variation of the lab equipment itself, meaning your body’s own day-to-day fluctuation matters more than how precisely the machine measures the sample.³ This built-in wobble is one reason many urologists recommend repeating a borderline PSA test before jumping to a biopsy.

Aging and Prostate Size

PSA tends to climb gradually as men get older, and the main reason is straightforward: the prostate itself grows. Benign prostatic hyperplasia (BPH), the noncancerous enlargement that affects most men as they age, adds more tissue that produces PSA. A large screening study found that every 10 cubic centimeter increase in prostate volume roughly doubled the odds of a PSA reading above 4 ng/mL.⁴ Age also has an independent effect on PSA beyond what prostate size alone would predict.⁵

To put some numbers on it: one study found that men without prostate cancer who also had no BPH averaged PSA around 0.78 ng/mL if they were under 60, and about 1.23 ng/mL if they were 60 or older. Add BPH to the picture and those figures rose to roughly 0.97 and 1.75 ng/mL, respectively.⁶ The upshot is that a gradually rising PSA over the years is expected and, by itself, does not point to cancer.

Inflammation and Infection

Anything that inflames the prostate can push PSA up sharply. Chronic prostatitis, which can smolder for months without dramatic symptoms, is a well-recognized cause of elevated readings. Treating chronic prostatitis with antibiotics and anti-inflammatory drugs brought PSA back to normal in roughly half of patients in one study, eliminating the immediate need for biopsy in those men.⁷ A separate analysis confirmed the same pattern, finding that in nearly half of men with both elevated PSA and chronic prostatitis, treatment alone brought PSA back into the normal range.⁸

Subclinical inflammation, the kind you would not even know you had without a biopsy, also contributes. One study comparing men with high versus normal PSA found that prostatic inflammation accounted for about 7 percent of the variance in PSA levels, independent of prostate size.⁹ That may not sound like much, but for a man sitting near the biopsy-decision threshold of 4 ng/mL, it can be enough to tip the number one way or the other.

Acute infections are a more dramatic story. A febrile urinary tract infection can send PSA soaring, sometimes above 100 ng/mL, and the return to baseline is slow. In men who had a febrile UTI, the total PSA during the acute phase rose by a median of about 14 ng/mL, and it took months to come back down. Even six months after the infection, complexed PSA and total PSA remained elevated in many men, and the ratio of free-to-total PSA mimicked patterns seen in prostate cancer, creating a genuine risk of misdiagnosis.¹⁰ This is why guidelines discourage PSA testing during or shortly after an active urinary infection.¹¹

Ejaculation

Sexual activity has a measurable but short-lived effect on PSA. In men aged 49 to 79, PSA jumped by an average of about 41 percent one hour after ejaculation. By 24 hours, roughly 92 percent of men had returned to baseline, and by 48 hours, 97 percent were back.¹² Other studies have confirmed the one-hour spike and the rapid return, with some finding the bump statistically insignificant by five hours.¹³ The practical advice most urologists give is to avoid ejaculation for 48 hours before a scheduled PSA test. For men with a borderline reading, this matters more than for men whose PSA is clearly low or clearly high, but it is a simple precaution that removes one variable from the equation.

Exercise and Mechanical Pressure

Vigorous exercise, especially activities that put pressure on the perineum, can nudge PSA upward. Long-distance cycling is the best-studied example. In men aged 50 and over, a prolonged bike ride raised total PSA by an average of about 9.5 percent, and the number of riders who crossed the 4 ng/mL threshold tripled from two to six.¹⁴ The rise correlated with both age and distance ridden. If you are an avid cyclist and your PSA comes back slightly high, your doctor may want to retest after a rest period before drawing conclusions.

Medical Procedures

Anything that physically disturbs the prostate can release large amounts of PSA into the blood. A prostate biopsy causes a median spike of about 7.9 ng/mL, and it typically takes two to three weeks for PSA to settle back to its baseline level. In some men, PSA was still elevated after four weeks, which is why the recommendation is to wait at least six weeks after a biopsy or a transurethral resection before drawing PSA again.¹⁵ Urinary retention and catheterization can produce similar spikes through mechanical distension and trauma to the prostate.¹⁶

Medications That Lower PSA

Two widely prescribed drugs, finasteride and dutasteride, directly suppress PSA by shrinking the prostate. Both belong to a class called 5-alpha reductase inhibitors, which block the conversion of testosterone to DHT. Finasteride at the standard 5 mg dose cut total PSA by about 50 percent within six months in a placebo-controlled trial.¹⁷ Dutasteride, which blocks both isoforms of the enzyme, tends to reduce prostate volume by slightly more, roughly 23 percent after a year compared with about 20 percent for finasteride.¹⁸

Even the lower doses used for hair loss treatment made a measurable dent, reducing PSA by an average of about 28 percent overall. Around 80 percent of men on low-dose treatment saw a decrease, while the remaining 20 percent saw stable or slightly rising PSA. A noticeable drop appeared even after just three to six months of use.¹⁹ The clinical catch here is important: if you are on one of these drugs and your doctor does not know it, a seemingly “normal” PSA may actually be masking a doubling of the true level. Most guidelines advise doubling the measured PSA for men on a 5-alpha reductase inhibitor to get a corrected estimate.

Testosterone Replacement Therapy

Going in the opposite hormonal direction, testosterone replacement therapy (TRT) tends to raise PSA, because androgens drive PSA production. A large randomized trial found that men on TRT saw a greater PSA increase than those on placebo, with the biggest difference appearing around 12 months, when the gap was about 0.15 ng/mL. After the first year, the difference between groups narrowed and was no longer statistically significant.²⁰ In the Testosterone Trials, PSA rose by about 0.47 ng/mL over 12 months in the treatment group versus just 0.06 ng/mL on placebo. About 5 percent of treated men saw their PSA jump by more than 1.7 ng/mL, and nearly 2 percent had their PSA rise above 4 ng/mL.²¹

For men starting TRT, regular PSA monitoring is standard practice. A sharp, sustained rise is worth investigating, but a modest bump during the first year is expected and does not necessarily signal trouble.²²

Time of Day and Season

PSA has a diurnal rhythm. Research has shown that the timing of a blood draw within the day can shift the result enough to influence a biopsy decision.²³ There is also some evidence of seasonal variation. One large population-based study found that PSA was slightly higher in spring than in other seasons, although the difference was small and disappeared after adjusting for age. Interestingly, age-adjusted PSA was higher on Thursdays and Fridays than earlier in the week.²⁴ A separate study linked total PSA to sunlight exposure and seasons, though the free-to-total PSA ratio was unaffected.²⁵ None of these time-based shifts are large enough to warrant rescheduling a test, but they add one more layer of background noise to the measurement.

Lab Equipment and Assay Differences

Not all PSA tests are created equal. Different lab platforms use different antibodies and calibration standards to measure PSA, and the results can disagree meaningfully. One study comparing several commercial assay systems found that while results were broadly correlated, the bias between platforms ranged from about 0.8 to nearly 6 ng/mL. That disagreement was large enough to reclassify cancer risk categories and to miss biochemical recurrence after treatment in more than half of cases when a man’s samples were run on a different machine than the one used for his baseline.²⁶ The practical lesson is to try to get your PSA measured at the same lab each time. Switching labs introduces an artificial change that has nothing to do with your prostate.

Ethnic and Demographic Differences in Baseline PSA

PSA levels are not the same across all ethnic groups even in men without prostate disease. A systematic review found that Black men consistently had higher PSA levels than White men, while Hispanic men had levels similar to White men.²⁷ Research on young men without cancer has also documented differences in baseline PSA and the rate at which PSA rises over time among Chinese, African American, and Caucasian American men.²⁸ These differences matter because a single universal threshold like 4 ng/mL does not work equally well for everyone. Some researchers advocate ethnicity-adjusted reference ranges, though this remains an area of active debate.

Repeat Testing and the Biopsy Decision

Given all the sources of variation above, repeating a borderline PSA before committing to a biopsy makes intuitive sense. An analysis from a large screening study looked at men with PSA between 3 and 10 ng/mL who had two tests within eight weeks. Skipping biopsy when the second PSA dropped to 3 ng/mL or below would have saved about 17 percent of biopsy procedures while missing about 5 percent of clinically significant cancers.²⁹ That tradeoff is not perfect, which is why doctors increasingly use additional tools to refine the picture.

The percentage of free PSA (the fraction not bound to proteins) can help separate benign from malignant causes. A lower free-PSA percentage raises suspicion for cancer, while a higher percentage suggests BPH. Research has recommended that percent-free PSA should accompany standard PSA testing, and that both values should be repeated when they fall near a decision threshold, precisely because fluctuation is so common.³⁰ PSA density, which divides PSA by prostate volume measured on ultrasound, is another way to account for the fact that bigger prostates naturally produce more PSA.³¹ The degree of PSA fluctuation itself may also carry diagnostic value. One study found that fluctuation, combined with PSA density and percent-free PSA, was associated with the presence of prostate cancer, suggesting that the pattern of change over time provides information beyond any single reading.³²

Supplements and Saw Palmetto

Saw palmetto is one of the most popular over-the-counter supplements marketed for prostate health, and men often wonder if it affects their PSA. The evidence is mixed enough to be frustrating. A well-designed randomized trial using escalating doses of saw palmetto found no difference in PSA change between the supplement and placebo groups over 72 weeks.³³ On the other hand, a trial using a phytosterol-enriched formulation of saw palmetto oil did report a significant PSA reduction compared with placebo after 12 weeks.³⁴ The formulation differences between products may explain the conflicting results. For PSA monitoring purposes, the safest assumption is that standard saw palmetto is unlikely to meaningfully shift your number, but always tell your doctor what supplements you take so they can factor it in.

PSA Beyond the Prostate

Despite its name, prostate-specific antigen is not entirely prostate-specific. Small amounts of PSA are produced by other tissues. The fluid with the second-highest concentration of PSA after seminal plasma is actually nipple aspirate fluid from the female breast, and lactating women have measurable PSA in breast milk.³⁵ In men, these non-prostatic sources contribute very little to the blood level and are not a practical concern for screening. But the misnomer is a reminder that PSA is a tissue marker whose blood levels reflect the state of the whole prostate gland, not a direct readout of cancer activity. That single fact is the most important thing to carry into any conversation about a PSA result that has gone up, down, or sideways between visits.